WuXi Biologics (Cayman) Inc. (Stock Code: 02269) Announces Change in Issued Shares
Bulletin Express
Nov 10
On 10 November 2025, WuXi Biologics (Cayman) Inc. disclosed a change in its issued share capital. The total number of issued shares rose from 4,075,052,254 to 4,079,107,254 following the issuance of shares under a Pre-IPO Share Option Scheme adopted on 5 January 2016 (as amended on 10 August 2016).
A total of 55,000 newly issued shares were allotted at HKD 1.41 per share, representing approximately 0.00135% of the previously issued share count. An additional 4,000,000 shares were issued at HKD 1.29 each, representing approximately 0.09816% of the previous total. The resulting closing balance of issued shares stands at 4,079,107,254.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.